Peptomyc Investors
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Investors
.png)
.png)
Investor Type:
Healthcare Company
Technology:
Advanced Longevity (R&D)
Founded Date:
2014
Industry:
Advanced and Next Generation Therapies (Various)
Employee Number:
1-10
Headquarters:
Barcelona, Catalonia, Spain